HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BAD dephosphorylation and decreased expression of MCL-1 induce rapid apoptosis in prostate cancer cells.

Abstract
PTEN loss and constitutive activation of the PI3K signaling pathway have been associated with advanced androgen-independent prostate cancer. PTEN-deficient prostate cancer C42Luc cells survive in serum-free media and show relative resistance to apoptosis even in the presence of the PI3K inhibitor ZSTK474. Yet, when ZSTK474 is combined with the translation inhibitor cycloheximide, C42Luc cells undergo apoptosis within 6 hours. We identified dephosphorylation of BAD (Bcl2-associated death promoter) as a main apoptosis-regulatory molecule downstream from PI3K, and loss of MCL-1 (Myeloid cell leukemia -1) as a major target of cycloheximide. The combination of MCL-1 knockdown and expression of phosphorylation-deficient mutant BAD2SA is sufficient to trigger rapid apoptosis in prostate cancer cells. These results establish the mechanism for the synergistic induction of apoptosis by the combination of a PI3K inhibitor and of a protein synthesis inhibitor in PTEN-deficient prostate cancer cells.
AuthorsDana Yancey, Kyle C Nelson, Daniele Baiz, Sazzad Hassan, Anabel Flores, Ashok Pullikuth, Yelena Karpova, Linara Axanova, Victoria Moore, Guangchao Sui, George Kulik
JournalPloS one (PLoS One) Vol. 8 Issue 9 Pg. e74561 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24040284 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • BAD protein, human
  • Culture Media, Serum-Free
  • MCL1 protein, human
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors
  • Protein Synthesis Inhibitors
  • Triazines
  • ZSTK474
  • bcl-Associated Death Protein
  • Cycloheximide
  • PTEN Phosphohydrolase
  • PTEN protein, human
Topics
  • Apoptosis (drug effects)
  • Cell Line, Tumor
  • Culture Media, Serum-Free (chemistry)
  • Cycloheximide (pharmacology)
  • Drug Resistance, Neoplasm (drug effects, genetics)
  • Drug Synergism
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Male
  • Myeloid Cell Leukemia Sequence 1 Protein (antagonists & inhibitors, genetics, metabolism)
  • PTEN Phosphohydrolase (deficiency, genetics)
  • Phosphatidylinositol 3-Kinases (genetics, metabolism)
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • Protein Kinase Inhibitors (pharmacology)
  • Protein Synthesis Inhibitors (pharmacology)
  • Signal Transduction
  • Triazines (pharmacology)
  • bcl-Associated Death Protein (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: